Outputs (3)

An exploration of the direct biological targets of molecular hydrogen (2024)
Book Chapter
Hancock, J., May, J. E., LeBaron, T. W., Punampalam, R., & Russell, G. (2024). An exploration of the direct biological targets of molecular hydrogen. In J. Slezak, & B. Kura (Eds.), Molecular Hydrogen in Health and Disease (21-38). Springer. https://doi.org/10.1007/978-3-031-47375-3

Molecular hydrogen (H2), supplied either as a gas or in a solution, has been gaining popularity as a treatment for a variety of conditions and diseases. For example, it has been suggested to be beneficial for neurodegenerative diseases, to ease the i... Read More about An exploration of the direct biological targets of molecular hydrogen.

Molecular hydrogen as a beneficial postharvest treatment (2023)
Book Chapter
Hancock, J. T., LeBaron, T. W., May, J., Thomas, A., Zulfiqar, F., & Russell, G. (2024). Molecular hydrogen as a beneficial postharvest treatment. In V. Ziogas, & F. J. Corpas (Eds.), Oxygen, Nitrogen and Sulfur Species in Post-Harvest Physiology of Horticultural Crops (303-318). Elsevier. https://doi.org/10.1016/B978-0-323-91798-8.00011-4

Molecular hydrogen (H2) has been shown to have significant effects in plants, especially during stress responses. H2 treatment can be used as a gas or as an H2-enriched solution, often termed hydrogen-rich water (HRW). Cellular effects of H2 are ofte... Read More about Molecular hydrogen as a beneficial postharvest treatment.

The therapeutic potential of oxyhydrogen gas in oncology: A study on Epstein–Barr Virus-immortalised B-lymphoblastoid (TK6) cells (2023)
Journal Article
Russell, G., Thomas, A. D., Nenov, A., Mannings, G., & Hancock, J. T. (2023). The therapeutic potential of oxyhydrogen gas in oncology: A study on Epstein–Barr Virus-immortalised B-lymphoblastoid (TK6) cells. Hydrogen, 4(4), 746-759. https://doi.org/10.3390/hydrogen4040047

Cancer is a leading cause of mortality worldwide. B-cells are a keystone of the adaptive immune response and are essential for the presentation of tumor-associated antigens to various types of T-cells. Approximately 1.5% of global cancer cases, inclu... Read More about The therapeutic potential of oxyhydrogen gas in oncology: A study on Epstein–Barr Virus-immortalised B-lymphoblastoid (TK6) cells.